Kasim has a MSc in Economics at the London School of Economics, UK. Kasim Kutay has been CEO of Novo Holdings A/S, Denmark since September 1, 2016. Kasim is also a member of the Board of Directors of Novo Nordisk A/S and Novozymes A/S.
From 1989 up until 2007 Kasim was in a couple of positions in Morgan Stanley. He was Managing Director and Chairman of the European Healthcare Group. Kasim joined Moelis & Company in 2009 as a Partner and Co-head of Europe.
Kasim has been a member of the board in several companies as ConvaTec, CW+ Chelsea and Westminster Hospital NHS Foundation Trust and member of the Board of Trustees of Northwick Park Institute for Medical Research.